Hong Kong Stock News

China Youran Dairy Group stock has barely flinched in recent weeks, with a 7 day slip of about 6% sitting against a strong 90 day gain of roughly 37%. That calm surface hides a sharp earnings pivot. H1 2026 brought the company back into profit, with basic earnings per share of CN¥0.19 on revenue of CN¥10,626.7m. The real story for long term holders is not the short term price noise. It is the move from prior losses to a trailing 12 month profit and what that means for a stock trading on a P/E...

Central China Securities just delivered a quarter that looks stronger on paper than the modest share price would suggest. The stock closed at HK$1.795 on 27 August, with short term returns in the mid single digits, while quarterly earnings and margins reflect recent profitability. The headline from this earnings release is profit strength. Net income for Q2 2026 reached C¥250.6m and basic earnings per share came in at C¥0.05401. On a trailing twelve month basis, net profit margin is 26.9%...

Tomson Group stock closed at HK$2.165, broadly flat over the past week, yet the latest earnings raise a sharper question about what you are really paying for. The headline is valuation strain. The company now trades on a P/E of 51.8x while its trailing net profit margin sits at 12.5%, well below where it stood a year ago. For short term traders the price move looks calm. For longer term holders the mix of a high multiple, softer margins and a dividend yield of 6.24% with weak free cash flow...

The market has treated Beijing DeepZero Technology like a momentum story first and a media business second. The stock closed at HK$702.0 after a sharp run over the past three months, even as earnings over the last year moved into loss territory. That sets up a sentiment clash around this H1 2026 release. The single biggest tension point is valuation. Beijing DeepZero Technology is trading at a P/B multiple around 68x while net profit margins sit close to 1.9%, and recent results include a one...

Country Garden Services Holdings closed at HK$5.785, a stock that has inched higher over the past month while still carrying the scars of a weak margin story. The headline this half is earnings quality, not growth. Net income from continuing operations over the last twelve months sat at C¥544.672m on revenue of C¥49,668.727m, which translates into a very slim 1.1% net margin after a sizeable C¥1.0b one off hit. The market’s muted optimism now faces a sentiment reckoning as investors weigh...

DKE Holding walked into this earnings season with a premium story and a premium price tag. The stock closed at HK$66.2 after a rough month that left it down about 33%, even though reported earnings over the past year were described as high quality. The headline this time is a squeeze. First half 2026 revenue reached ¥1,010.8m, yet half year basic earnings per share came in at ¥0.77. That sits against a trailing net profit margin of 3.8% and a P/E near 40x, which leaves very little room for...

Beijing Gas Blue Sky Holdings entered this earnings release with the stock at HK$0.034 and flat over the past week, even after modest gains over the past three months. The story investors had focused on was recovery at a reasonable price. The numbers now on the table highlight a different pressure point. Margins have been squeezed, with net profit margin over the last year at 4% compared with 4.5% a year earlier, and trailing earnings growth turning negative. For a company trading at 9x P/E...

Consun Pharmaceutical Group closed at HK$13.79 on Thursday after a quiet few weeks, yet the latest half year earnings tell a much louder story. Revenue reached ¥1,784.7m with net income of ¥595.3m for H1 2026, which keeps margins comfortably in the low 30s. That margin resilience is the real headline today. Short term traders may see just a small move in the share price. Long term investors will likely focus on a P/E of 8.4x versus much higher industry averages and a dividend yield of 5.8%...

AK Medical Holdings came into this earnings print with a stock that had slipped about 9% over the past week and was roughly flat over the past month. Yet the latest half-year numbers tell a different story. Revenue reached C¥764.7m with net income of C¥196.7m, and basic earnings per share landed at C¥0.1768. For a medical device maker that lives or dies on profitable procedure volume, the headline this time is simple: profitability is holding up and earnings power looks intact, even if the...

Shanghai Junshi Biosciences came into this earnings day with a mixed recent track record, modestly higher over the past month but lower over three months, and the stock now sits at HK$19.40 after the market absorbed the latest numbers. The headline is simple: Q2 flipped the script on years of red ink at the quarterly level, with revenue of C¥969.9m and net income of C¥42.2m, even as the trailing 12 months still show a loss. For a clinical stage focused biotech, that shift in quarterly...

CNNC International stock closed at HK$4.22 on 27 August, with a modest gain over the past month. However, the latest half year numbers tell a much cooler story. Revenue for H1 2026 came in at HK$142.1m and basic earnings per share were HK$0.0108, well below the recent trailing run rate implied by a P/E of 11x. The headline this time is margin and profit squeeze. The company remains profitable over the last twelve months, but this interim print forces investors to question how durable the...

Nayuki Holdings stock closed at HK$0.67 today, capping a weak month in which the share price slipped modestly. The market reaction looks muted, yet the H1 2026 report carries a clear headline for long term investors. Revenue reached C¥1,938.021m in the half while the company still booked a net loss of C¥97.493m. That loss reduction story over several years, combined with a P/S ratio of 0.2x compared with a higher industry average, is now the central question for anyone assessing whether the...

China Zheshang Bank stock has barely budged over the past month, even as investors weighed a low P/E of 4.5x and forecasts for stronger revenue and earnings growth. Today's Q2 print puts that quiet skepticism under a harsher light. Basic earnings per share dropped to ¥0.064 and quarterly net profit came in at ¥1,832m, well below the seasonally stronger Q1 run rate. For a bank often viewed as a growth story trading at a discount, the headline this quarter is the pressure on profitability...

The market has treated EVA Precision Industrial Holdings like a problem stock for months, with the share price down roughly 18% over 90 days and trading on a low P/E of 5.2x. Yet the latest half year numbers land with a very different tone. Revenue for H1 2026 sits at HK$3,070.139m and basic earnings per share come in at HK$0.08. This leaves the trailing twelve month P/E looking compressed against both the Hong Kong machinery industry and close peers. Today is not just about a cheap stock. It...

Man Yue Technology Holdings stock has been treading water in recent weeks, yet today’s earnings pull the spotlight back to a single pressure point. The company is priced on a trailing P/E of 72.1x, far above the Hong Kong electronics peer group, while net profit margin over the past year sits at only 0.6%. That combination of a rich valuation and wafer thin profitability is the real story. The market now has to decide whether today’s modest earnings progress justifies that multiple or whether...

Lingbao Gold Group entered this reporting period on a strong run, with the stock up about 42% over three months and trading above an internal discounted cash flow estimate. The headline today is straightforward: earnings power remains the central story. Basic earnings per share for the first half of 2026 were ¥0.7272, supported by ¥7,988.239m in revenue and ¥972.414m in net income from ongoing operations. For a gold producer, that profit engine and the recent margin improvement are what the...

BOCOM International Holdings stock closed at HK$0.465 after a weak run over the past week and month. However, the real story sits in the latest half year loss. The H1 2026 report shows total revenue of HK$206.4m but a net loss of HK$76.6m, which keeps the investment case firmly focused on profitability rather than top line scale. For short term traders, the recent slide will draw attention. For longer term investors, the key question now is how to weigh that recurring loss profile against a...

Huishang Bank shares have drifted lower in recent weeks, yet the latest half year numbers tell a calmer story than the price chart suggests. The stock now trades on a P/E of about 3.6x while the bank reports a trailing net profit margin near 51%. That mix of low valuation and solid profitability is the real headline this season. The question for you is whether the market is fairly discounting future risks or reacting too heavily to past disappointments and dividend uncertainty. Is Huishang...

Genertec Universal Medical Group shares came into this earnings day on the back foot, with the stock down about 11% over the past three months, yet the latest numbers tell a calmer story than the price suggests. The headline is margin resilience. Net profit margin over the past year sits at 15.6%, slightly ahead of the prior year, and basic earnings per share for the latest half year are ¥0.63. For a healthcare services and financing group trading on a very low P/E and offering a high...

China Shengmu Organic Milk went into this earnings release with its stock at HK$0.36 and a modest gain over the past three months, yet still slightly down over the last week. The headline today is not the share price. It is the swing back into profit in the first half of 2026, with basic earnings per share of ¥0.008 and net income of ¥64.007m. That sits against a trailing twelve months that still show a sizeable loss. This is why the gap between a recovering income statement and a premium P/S...

Wing On Company International shareholders watched the stock drift lower over the past month, yet today’s H1 2026 earnings land with a different kind of jolt. The company remains loss making, with basic EPS for the half showing a loss of HK$0.317 per share and trailing twelve month earnings from continuing operations also in the red. At the same time, the stock trades on a P/S of 5.1x, well above sector levels. It also offers an 8.99% dividend yield that recent cash flows and earnings have...

Kunlun Energy stock has been grinding higher in recent weeks, yet today’s earnings drop a quiet question into that optimism. The shares come into this release with a roughly 8% gain over both one and three months, while the latest half year shows earnings per share of ¥0.383 and revenue of about ¥100.0b. The emotional pull is simple: recent momentum and a headline P/E of 10.3x invite investors to treat this as a straightforward value story. The numbers tell a more cautious tale of modest...

Investors pushed Xingfa Aluminium Holdings down again to HK$5.60, extending a three month slide that has already wiped more than 25% off the stock. The selloff reflects a sentiment reckoning rather than a simple take on headline earnings. The market is latching onto a visible profit squeeze, with trailing net margin down to 2.5% and a five year drift lower in earnings, and is treating H1 2026 as confirmation of that pressure. The key question now is whether this latest set of numbers...

Hong Kong Technology Venture walked into this earnings day with the stock drifting, down over the past month and quarter, and investors already conditioned to loss making numbers. The headline this time is not the top line. It is the deepening earnings strain, with a basic earnings per share loss of HK$0.10 in the first half of 2026 and trailing 12 month losses of HK$204.41m. The market now has to decide whether today's price move is a cool headed response to that pressure on profitability,...